Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Solomon

Showing results (541-550 of 1,211) with videos related to

Pageof 122
Sort By:
Journal of the American College of Cardiology|April 17, 2026
Interchangeability of the KCCQ-12 and KCCQ-23 Across >18,000 Participants Enrolled in 4 Large-Scale Trials of Heart FailureYasuhiro Hamatani, Brian L Claggett, Akshay S Desai, et al.
Circulation. Heart Failure|November 22, 2021
Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF TrialAkshay S Desai, Muthiah Vaduganathan, John G Cleland, et al.
JAMA|March 13, 2013
Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trialMihai Gheorghiade, Michael Böhm, Stephen J Greene, et al.
European Heart Journal. Cardiovascular Imaging|April 11, 2023
Regional contributions to impaired myocardial mechanical function in heart failure with preserved ejection fractionTor Biering-Sørensen, Maja Cikes, Mats C H Lassen, et al.
Heart Rhythm|March 8, 2007
Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: the VALIANT experienceKent Stephenson, Hicham Skali, John J V McMurray, et al.
JACC. Heart Failure|January 5, 2019
Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney DiseaseIris E Beldhuis, Peder L Myhre, Brian Claggett, et al.
American Heart Journal|April 30, 2017
The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) TrialCarolyn Y Ho, John J V McMurray, Allison L Cirino, et al.
Journal of Cardiac Failure|December 1, 2025
Refining Atrial Shunt Therapy for HFpEF: Lessons from Pivotal Randomized Trials and Emerging DirectionsDylan J Gyberg, Jan Komtebedde, Uma Mylavarapu, et al.
JAMA Network Open|September 14, 2023
Temporal Association Among Influenza-Like Illness, Cardiovascular Events, and Vaccine Dose in Patients With High-Risk Cardiovascular Disease: Secondary Analysis of a Randomized Clinical TrialSheila M Hegde, Brian L Claggett, Jacob A Udell, et al.
JACC. Basic to Translational Science|December 14, 2021
Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized TrialThorsten M Leucker, William O Osburn, Paula Reventun, et al.
Pageof 122

Showing results (541-550 of 1,211) with videos related to

Sort By:
Pageof 122
Journal of the American College of Cardiology|April 17, 2026
Interchangeability of the KCCQ-12 and KCCQ-23 Across >18,000 Participants Enrolled in 4 Large-Scale Trials of Heart FailureYasuhiro Hamatani, Brian L Claggett, Akshay S Desai, et al.
Circulation. Heart Failure|November 22, 2021
Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF TrialAkshay S Desai, Muthiah Vaduganathan, John G Cleland, et al.
JAMA|March 13, 2013
Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trialMihai Gheorghiade, Michael Böhm, Stephen J Greene, et al.
European Heart Journal. Cardiovascular Imaging|April 11, 2023
Regional contributions to impaired myocardial mechanical function in heart failure with preserved ejection fractionTor Biering-Sørensen, Maja Cikes, Mats C H Lassen, et al.
Heart Rhythm|March 8, 2007
Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: the VALIANT experienceKent Stephenson, Hicham Skali, John J V McMurray, et al.
JACC. Heart Failure|January 5, 2019
Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney DiseaseIris E Beldhuis, Peder L Myhre, Brian Claggett, et al.
American Heart Journal|April 30, 2017
The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) TrialCarolyn Y Ho, John J V McMurray, Allison L Cirino, et al.
Journal of Cardiac Failure|December 1, 2025
Refining Atrial Shunt Therapy for HFpEF: Lessons from Pivotal Randomized Trials and Emerging DirectionsDylan J Gyberg, Jan Komtebedde, Uma Mylavarapu, et al.
JAMA Network Open|September 14, 2023
Temporal Association Among Influenza-Like Illness, Cardiovascular Events, and Vaccine Dose in Patients With High-Risk Cardiovascular Disease: Secondary Analysis of a Randomized Clinical TrialSheila M Hegde, Brian L Claggett, Jacob A Udell, et al.
JACC. Basic to Translational Science|December 14, 2021
Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized TrialThorsten M Leucker, William O Osburn, Paula Reventun, et al.
Pageof 122